Medibank Private Limited (MDBPF) Stock Price & Analysis
Medibank Private Limited (MDBPF) — price $3.90 (0.00%), as of the Nov 19, 2026 trading session; market cap $10.7B. Expected results Feb 24, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Medibank Private Limited · MDBPF · Financial Services · Insurance Life
Medibank Private Limited is an Australian firm specializing in private health insurance and health-related services. The company's operations are divided into two principal segments: Health Insurance and Medibank Health.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $3.90 | |
| Change on the day | 0.00% | |
| 52-week range | $2.78–$3.90 | |
| Market capitalisation | $10.7B | |
| Price / earnings (trailing) | 22.83 | |
| Shares traded on the day | 300 | |
| Beta (volatility vs the S&P 500) | 0.05 | |
| Dividends per share (last 12 months) | $0.14 | |
| Dividend yield (last 12 months) | 3.53% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for Medibank Private (MDBPF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 14, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Medibank Private (MDBPF), and what does it report?
Short answer · as of
Medibank Private Limited is an Australian firm specializing in private health insurance and health-related services. The company's operations are divided into two principal segments: Health Insurance and Medibank Health. Medibank Private Limited (MDBPF) is classified as Financial Services / Insurance Life. Headquarters: 695 Collins Street, Docklands, VIC, 3008, AU. It employs 5,001 people. The market values it at $10.7B.
What are the financial strengths and risks for Medibank Private (MDBPF)?
Short answer · as of
The distress and quality screens read Altman Z 7.55 · Piotroski F 6. Trailing ratios: ROE 26.7% · ROA 13.4% · earnings yield 4.4% · free-cash-flow yield 4.2%.
What should you watch next at Medibank Private (MDBPF)?
Short answer · as of
The next earnings report is expected on Feb 24, 2027. The number it tests is the $0.23 EPS analysts carry for it. Analyst estimates on file carry FY2026 revenue $9.17B · EPS 0.23 · 5 analysts.
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
- No quarterly income statement is held for MDBPF.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
How is Medibank Private scored?
Research dated 2026-09-13.
Compared with a conventional health insurer, Medibank reaches beyond underwriting. It serves overseas visitors and students and sells health management, in-home care and telehealth services to government and corporate entities; it also distributes travel, life and pet cover.
That mix creates exposure to policy activity and service contracts, whereas a pure insurer is more concentrated in underwriting. The life-insurance label is not a useful shorthand: private health cover is the core described business, and life insurance is a distributed product within a wider offering.
| Company | Price | Market value | Score |
|---|---|---|---|
| $43.09 Nov 19, 2026 | $11.6B | — 5-pillar · not comparable | |
| $46.62 Nov 19, 2026 | $11.8B | — 5-pillar · not comparable | |
| $105.86 Nov 19, 2026 | $7.59B | — 5-pillar · not comparable | |
| $315.92 Nov 19, 2026 | $15.5B | — 5-pillar · not comparable | |
| $64.60 Nov 18, 2026 | $6.60B | — 5-pillar · not comparable | |
| $44.19 Nov 19, 2026 | $5.94B | — 5-pillar · not comparable | |
| $63.79 Nov 19, 2026 | $5.61B | — 5-pillar · not comparable | |
| $26.69 Nov 19, 2026 | $5.31B | — 5-pillar · not comparable | |
| $36.47 Nov 19, 2026 | $4.61B | — 5-pillar · not comparable | |
| $74.37 Nov 19, 2026 | $3.27B | — 5-pillar · not comparable | |
| $38.23 Nov 19, 2026 | $2.85B | — 5-pillar · not comparable | |
| $35.87 Nov 19, 2026 | $1.55B | — 5-pillar · not comparable |
The comparison model is unavailable. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Revenue estimate
- $9.17B
- EPS estimate
- $0.23
Measured against a quoted price of $3.90 (as of Nov 19, 2026).
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held MDBPF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported MDBPF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Medibank Private Financial Services Stock: Key Questions Answered
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
How do Medibank and ahm fit into the business?
Medibank and ahm are the brands used to underwrite the company’s private health policies, including hospital and ancillary cover. They sit within the insurance operation rather than the health-services arm.
What does Medibank Health sell to government and corporate clients?
Medibank Health provides health management, in-home care and telehealth services. This contract-based activity broadens the business beyond collecting premiums and underwriting health cover.
What is the MDBPF stock price today?
The last price recorded for Medibank Private Limited (MDBPF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
Does MDBPF pay a dividend?
Yes. The dividend yield of Medibank Private Limited (MDBPF) over the last 12 months, with its date, is listed under Price & valuation on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 22 figures on this page — 14 from Financial Modeling Prep (FMP), 5 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com